{"id": "375907", "url": "https://fevir.net/resources/Evidence/375907", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence"], "versionId": "11", "lastUpdated": "2025-08-15T10:17:51.868Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan", "author": [{"name": "Joanne Dehnbostel"}], "citeAs": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375907. Revised 2025-08-15. Available at: https://fevir.net/resources/Evidence/375907. Computable resource at: https://fevir.net/resources/Evidence/375907#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial", "reference": "Composition/375280"}}], "statistic": [{"quantity": {"unit": "mm Hg", "value": -4.5}, "sampleSize": {"knownDataCount": 53, "numberOfParticipants": 62, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed", "valueUnsignedInt": 60}]}, "statisticType": {"coding": [{"code": "STATO:0000457", "system": "https://fevir.net/sevco", "display": "difference in means"}]}, "attributeEstimate": [{"type": {"coding": [{"code": "STATO:0000196", "system": "https://fevir.net/sevco", "display": "confidence interval"}]}, "level": 0.95, "range": {"low": {"unit": "mm Hg", "value": -10.82}, "high": {"unit": "mm Hg", "value": 1.32}}}, {"type": {"coding": [{"code": "STATO:0000700", "system": "https://fevir.net/sevco", "display": "p-value"}]}, "quantity": {"value": 0.123}}]}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "375907", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Evidence", "variableDefinition": [{"observed": {"type": "EvidenceVariable", "display": "GroupAssignment: Quadpill vs. Candesartan", "reference": "EvidenceVariable/375183"}, "variableRole": "exposure", "comparatorCategory": "Candesartan 8 mg once daily"}, {"observed": {"type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375185"}, "variableRole": "outcome"}, {"observed": {"type": "Group", "display": "Enrolled Group for QUARTET USA Trial (372797)", "reference": "Group/372797"}, "variableRole": "population"}], "name": "Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan", "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}